Human IgG antibody Laboratories manufactures the promega pd-1/pd-l1 cell reagents distributed by Genprice. The Promega Pd-1/Pd-L1 Cell reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Promega. Other Promega products are available in stock. Specificity: Promega Category: Pd-1/Pd-L1 Group: Cell
Anti-PD-L1 |
|||
| DB-241-RTU-7 | DB Biotech | 7 ml | EUR 433 |
|
Description: rabbit monospecific clonal antibodies for ihc-p application; prediluted (ready to use) |
|||
PD-L1 Antibody |
|||
| 4059-002mg | ProSci | 0.02 mg | EUR 171.82 |
|
Description: PD-L1 plays a critical role in induction and maintenance of immune tolerance to self. As a ligand for the inhibitory receptor PDCD1/CD279, PD-L1 modulates the activation threshold of T-cells and limits T-cell effector response (1). The PDCD1/CD279-mediated inhibitory pathway is exploited by tumors to attenuate anti-tumor immunity and facilitate tumor survival (2,3). Through a yet unknown activating receptor, it may costimulate T-cell subsets that predominantly produce interleukin-10 (IL10) (4). |
|||
PD-L1 Antibody |
|||
| 4059-01mg | ProSci | 0.1 mg | EUR 436.42 |
|
Description: PD-L1 plays a critical role in induction and maintenance of immune tolerance to self. As a ligand for the inhibitory receptor PDCD1/CD279, PD-L1 modulates the activation threshold of T-cells and limits T-cell effector response (1). The PDCD1/CD279-mediated inhibitory pathway is exploited by tumors to attenuate anti-tumor immunity and facilitate tumor survival (2,3). Through a yet unknown activating receptor, it may costimulate T-cell subsets that predominantly produce interleukin-10 (IL10) (4). |
|||
PD-L1 Peptide |
|||
| 46-156P | ProSci | 0.1 mg | EUR 338 |
|
Description: CD274 / PD-L1 Peptide |
|||
PD-L1 Peptide |
|||
| 4059P | ProSci | 0.05 mg | EUR 164.75 |
|
Description: (IN) PD-L1 peptide |
|||
B7-H1/PD-L1 |
|||
| E21-315 | EnoGene | 10ug | EUR 343 |
Mouse PD-L1 Antibody |
|||
| 32903-05111 | AssayPro | 150 ug | EUR 261 |
Anti-PD-L1 antibody |
|||
| STJ130022 | St John's Laboratory | 50 µl | EUR 321 |
|
Description: Programmed death-ligand 1 (PD-L1) is a 40kDa type 1 transmembrane protein that suppresses immune system. PD-L1 is expressed in hematopoietic and nonhematopoietic cells including T cells and B cells and various types of tumor cells. PD-L1 binds to its receptor Programmed death 1 (PD1). During infection or inflammation, PD1PD-L1 interaction is important for preventing autoimmunity. In tumor microenvironments, PD1-PD-L1 interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation. Expression of this gene in tumor cells is considered to be prognostic in many types of human cancers. In recent years, PDL1 has become an important biomarker and immunotherapy target for many types of malignancies. |
|||
Anti-PD-L1 antibody |
|||
| STJ130023 | St John's Laboratory | 50 µl | EUR 321 |
|
Description: Programmed death-ligand 1 (PD-L1) is a 40kDa type 1 transmembrane protein that suppresses immune system. PD-L1 is expressed in hematopoietic and nonhematopoietic cells including T cells and B cells and various types of tumor cells. PD-L1 binds to its receptor Programmed death 1 (PD1). During infection or inflammation, PD1PD-L1 interaction is important for preventing autoimmunity. In tumor microenvironments, PD1-PD-L1 interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation. Expression of this gene in tumor cells is considered to be prognostic in many types of human cancers. In recent years, PDL1 has become an important biomarker and immunotherapy target for many types of malignancies. |
|||
Anti-PD-L1 antibody |
|||
| STJ130024 | St John's Laboratory | 50 µl | EUR 321 |
|
Description: Programmed death-ligand 1 (PD-L1) is a 40kDa type 1 transmembrane protein that suppresses immune system. PD-L1 is expressed in hematopoietic and nonhematopoietic cells including T cells and B cells and various types of tumor cells. PD-L1 binds to its receptor Programmed death 1 (PD1). During infection or inflammation, PD1PD-L1 interaction is important for preventing autoimmunity. In tumor microenvironments, PD1-PD-L1 interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation. Expression of this gene in tumor cells is considered to be prognostic in many types of human cancers. In recent years, PDL1 has become an important biomarker and immunotherapy target for many types of malignancies. |
|||
Anti-PD-L1 antibody |
|||
| STJ180217 | St John's Laboratory | 0.1 ml | EUR 280 |
Anti-PD-L1 antibody |
|||
| STJ180383 | St John's Laboratory | 0.1 ml | EUR 246 |
Anti-PD-L1 antibody |
|||
| STJ190082 | St John's Laboratory | 200 µl | EUR 197 |
|
Description: Unconjugated Mouse monoclonal to PD-L1 (AS1A7) |
|||
PD-L1 (CD274) siRNA |
|||
| 20-abx910978 | Abbexa |
|
|
PD-L1 (CD274) siRNA |
|||
| 20-abx910979 | Abbexa |
|
|
PD-L1 Rabbit pAb |
|||
| A1645-100ul | Abclonal | 100 ul | EUR 308 |
PD-L1 Rabbit pAb |
|||
| A1645-200ul | Abclonal | 200 ul | EUR 459 |